@paradigmmedcom

paradigmmedcom has been a member of Linktree for 6 years and joined in September 2019. The social media accounts linked to from paradigmmedcom are: • Facebook • Instagram • LinkedIn • X Besides social media accounts, paradigmmedcom has populated their site with: • Accredited Activity 1416-4 - nAMD • Modern Treatment of Neovascular Retinal Diseases: Minimizing Injection Burden, Optimizing Outcomes • Optimizing First-Line Treatment of Advanced RCC in the Era of Combination Therapies • Breaking Barriers to Nonproliferative Diabetic Retinopathy Care: Challenges and Opportunities for Optometrists • Trials Vs Reality: Matching Clinical and Real-World Evidence With Second-Generation Retinal Therapies • Accredited Activity 1345-2 - nAMD • Pathways to Care: Updates on CSU • Case Consult: Clinical Insights on ADCs for HER2 • The Science and Art of Retina: Exploring the Role of Ang-2 and VEGF Inhibition Across Common Clinical Scenarios • Beyond the Clinical Trials: The Real-World Impact of Second-Generation Therapy • Fresh Perspectives on Pulmonary Arterial Hypertension: A Patient-Centered Approach to Care • Accredited Activity 1416-2 - nAMD • 1415-5 Did You Know? Getting Into the Details About Managing DR/DME – Patient Simulation - DME • Advancements in Idiopathic Nephrotic Syndrome: Updates on Clinical Trial Data and Management • Imaging-Based Retinal Decision-Making in the Era of Second-Generation Therapy • Decision Points in CSU: Ten Questions Asked and Answered • Innovations in Sustained Treatment of nAMD: An Update on TKI Therapies From ARVO 2026 • paradigmmed.org • Treatment of RVO with Macular Edema Using New Anti-VEGF Agents | Eye Conenct • Expert Analysis of HER2-Low and HER2-Ultralow Updates to Pathology Practice • Advances in Primary Membranous Nephropathy: A Clinical Update on Management • The Latest Updates on the Role of HER2-Low and HER2-Ultralow in Treatment Selection for Metastatic Breast Cancer • Food Allergy: Best Practices in Shared Decision-Making • New Anti-VEGF Therapies For nAMD | AAO | Eye Connect • Reading Between the Lines: Nuanced Decision-Making With Sustained Delivery Therapies • Expert Insights on Managing IDH- and FLT3-Mutant AML: Bringing Precision Medicine to Daily Practice • Aligning Patient, Care Partner, and Provider Priorities for the Management of Obesity: Clinician Edition • Taking Action to Reduce Pain at IUD Insertion: Demonstration Techniques for Paracervical Block at IUD Insertion • Common Practice Dilemmas in the Age of Second-Generation Therapy A Retina Unplugged Podcast Activity • The Many Faces of Neovascular Retinal Disease: Individualizing the Use of Sustained Delivery Therapy • Diverse Applications of Sustained Delivery Therapy in Retinal Vascular Diseases • “Delivering” on the Promise of Sustained Treatment: Innovations in Long-Term Disease Control • Treatment of Macular Edema Secondary to RVO With Intravitreal Anti-VEGF Therapy • Diabetic Retinopathy: Durable Anti-VEGF Strategies for DME Treatment • The Expanding IBD Toolbox: Targeting TL1A • Transforming AML Care: Expert Approaches to IDH- and FLT3-Mutant Management • Accredited Activity A1403-1 – AAO Eye Connect RVO • Discovering New Targets and Unique Strategies to Treat Sjögren’s Disease • Driving Toward Better Schizophrenia Care: Finding Another Route in a Complex Disease With Long-Acting Injectable Medications • Accredited Activity 1345-1 - nAMD • Accredited Activity 1345-3 - nAMD • Accredited Activity 1345-4 - nAMD • Accredited Activity 1345-5 - nAMD • Improving Outcomes for Patients With Tenosynovial Giant Cell Tumor • “Fact Vs Fiction”: Dispelling Myths and Misinformation on the Use of Biostimulatory Fillers in Regenerative Aesthetics • Clinical Mastery of Facial Rejuvenation in Ethnic Patient Populations: Achieving Aesthetic Balance through Individualized Treatment • Molluscum Contagiosum: To Treat or Not to Treat New and Emerging Treatment Strategies • Visit our Website! • Paradigm Course Catalog • Applying New Guidelines and New Treatments for Patients With Lupus Nephritis • Psoriasis Prime Time: The Role of TYK Inhibition in Psoriasis • Psoriasis With Scalp Involvement in a Patient With Skin of Color • Diagnosis and Management of CSU Across Diverse Skin Colors: A Case Consult • A Treatment-Naïve Patient With PDR and DME – Case Consult - DME • Recalcitrant DME – A CME Case Consult - DME • Using Durable Next-Generation Anti-VEGF Agents to Treat DME • Revolutionizing Neovascular Retinal Disease Treatment: Update on Tyrosine Kinase Inhibitors and Gene Therapies • The Expanding Use of Immunotherapies for Melanoma: Advances and Clinical Applications • Advances in Regenerative.. • Advances in Durable Treatments for the Management of nAMD • Reduce Vision Loss in nAMD Using Long-Acting Anti-VEGF Therapies • Guideline Adherent Care in the Management of Glaucoma - A Just in Time Sorting Game Case • www.eye-connect.org • Conversations in Tailoring Treatment of Complex Patients With Inflammatory Bowel Disease • CrowdWisdom • Informed Choices in NSCLC: Optimal Use of Immunotherapies Across All Stages of Disease • Adapting to Durable Anti-VEGF Strategies for DME Treatment • Ask the Experts: Insights on Influenza Diagnosis and Management • In the Clinic: A Case-Based Discussion on Managing CSU • New Horizons in the Management of Chronic Spontaneous Urticaria • New and Noteworthy Updates in DME Management | Infographic • Treatment-Naïve DME - A Case Consult | Eye Connect • [BRONZE] Psoriasis Prime Time: TYK Inhibition in Hard-to-Treat Psoriasis • [SILVER] The Expanding Use of Immunotherapies for Melanoma: Advances and Clinical Applications • [GOLD] How Dry Am I? A Case-Based Guide to Treating Retinal Vascular Diseases • [GOLD] Alzheimer's Disease Dual-Tracked Interactive DASHboard Webinar • Infographic-Enhanced Journal Club Activity! Learn to describe the rationale for targeting HER3 in solid tumors, and summarize the latest data from ongoing clinical trials. Earn up to 0.25 CME credit • Optimizing Outcomes for Molluscum Contagiosum: Current and Emerging Treatment Strategies • Systemic Symptoms Associated With Breast Implants: Charting Patients’ Journeys With Their Primary Care Physician • BRONZE DIGITAL HEALTH AWARD WINNER: Getting to Control: Personalized Care to Address Health Inequities in the Diagnosis of Uncontrolled Severe Asthma and Treatment With Add-on Maintenance Biologic Therapy • GOLD DIGITAL HEALTH AWARD WINNER: The Future is Now: Targeting B Cells in Lupus Nephritis • MERIT DIGITAL HEALTH AWARD WINNER: Seeking Closure in Perianal Fistulizing Crohn’s Disease - Research Wrap-Up 1: Efficacy and Safety of Stem Cell Therapy for Complex Perianal Fistulas in Patients With Crohn’s Disease • MERIT DIGITAL HEALTH AWARD WINNER: A 22-Year-Old Presents With Shaving Bumps: A Mystery Case Presentation • Check It Out! Learn to describe the mechanisms of action for targeted agents, as well as make appropriate treatment plans and decisions for patients with psoriasis/PsA. Earn up to 1.0 FREE CME credits! • NEW ACTIVITY! Learn to examine the role of pathways beyond VEGF-A, compare treatments for neovascular retinal diseases, and select appropriate therapies for patients with nAMD & DME. • Review concepts of MCED tests, including detection via liquid biopsy, data supporting use as a screening tool, and identifying potential MCED test candidates • NEW MDS/AML interactive infographic #CE activity! Earn up to 0.50 hour CME or 0.5 contact hour (0.05 CEU) pharmacy credits. • Learn and earn 1.0 CME credit in this whiteboard webinar on Giant Cell Arteritis diagnosis, clinical trial data, and guideline-recommended treatment strategies • REGISTER FOR LIVE OR VIRTUAL: "Update in Food Allergy Management"